Ask AI
Atopic Dermatitis and IL-4/IL-13 and IL-13 Targeted Therapies
Interactive Case Challenges: Atopic Dermatitis and IL-4/IL-13 and IL-13 Targeted Therapies

Released: April 30, 2025

Activity

Progress
1
Course Completed

Case Description
Amy’s regimen is adjusted to include a nonsteroidal topical agent. Her symptoms continue to improve, and she reports a significant enhancement in her quality of life. During her 1-year follow-up, Amy’s AD is well controlled, but she has questions about maintaining remission.

What is the best strategy for long-term management of Amy’s AD?